Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiao-En Xu

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 17, 2013
Serum GFAP autoantibody as an ELISA-detectable glioma markerPing Wei, Wei Zhang, Liu-Song Yang, et al.
Breast Cancer Research and Treatment|March 25, 2022
The early-stage triple-negative breast cancer landscape derives a novel prognostic signature and therapeutic targetYun-Song Yang, Yi-Xing Ren, Cheng-Lin Liu, et al.
Journal for Immunotherapy of Cancer|July 29, 2021
MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancerSi-Yu Wu, Yi Xiao, Jin-Li Wei, et al.
Journal of Proteomics|October 9, 2012
iTRAQ-based quantitative proteomic analysis for identification of oligodendroglioma biomarkers related with loss of heterozygosity on chromosomal arm 1pLiu-song Yang, Xiao-en Xu, Xiu-ping Liu, et al.
Theranostics|October 12, 2020
SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancerXi-Yu Liu, Wang Jiang, Ding Ma, et al.
Cancer Medicine|November 16, 2018
DSCAM-AS1 regulates the G<sub>1</sub> /S cell cycle transition and is an independent prognostic factor of poor survival in luminal breast cancer patients treated with endocrine therapyWei Sun, An-Qi Li, Ping Zhou, et al.
Journal for Immunotherapy of Cancer|July 20, 2021
GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancerJin-Li Wei, Si-Yu Wu, Yun-Song Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2016
Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast CancerWen-Jia Zuo, Yi-Zhou Jiang, Yu-Jie Wang, et al.
Data in Brief|July 29, 2015
Data from a proteomic analysis of colonic fibroblasts secretomesSun-Xia Chen, Xiao-En Xu, Xiao-Qing Wang, et al.
Journal of Proteomics|August 14, 2014
Identification of colonic fibroblast secretomes reveals secretory factors regulating colon cancer cell proliferationSun-Xia Chen, Xiao-En Xu, Xiao-Qing Wang, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 17, 2013
Serum GFAP autoantibody as an ELISA-detectable glioma markerPing Wei, Wei Zhang, Liu-Song Yang, et al.
Breast Cancer Research and Treatment|March 25, 2022
The early-stage triple-negative breast cancer landscape derives a novel prognostic signature and therapeutic targetYun-Song Yang, Yi-Xing Ren, Cheng-Lin Liu, et al.
Journal for Immunotherapy of Cancer|July 29, 2021
MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancerSi-Yu Wu, Yi Xiao, Jin-Li Wei, et al.
Journal of Proteomics|October 9, 2012
iTRAQ-based quantitative proteomic analysis for identification of oligodendroglioma biomarkers related with loss of heterozygosity on chromosomal arm 1pLiu-song Yang, Xiao-en Xu, Xiu-ping Liu, et al.
Theranostics|October 12, 2020
SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancerXi-Yu Liu, Wang Jiang, Ding Ma, et al.
Cancer Medicine|November 16, 2018
DSCAM-AS1 regulates the G<sub>1</sub> /S cell cycle transition and is an independent prognostic factor of poor survival in luminal breast cancer patients treated with endocrine therapyWei Sun, An-Qi Li, Ping Zhou, et al.
Journal for Immunotherapy of Cancer|July 20, 2021
GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancerJin-Li Wei, Si-Yu Wu, Yun-Song Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2016
Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast CancerWen-Jia Zuo, Yi-Zhou Jiang, Yu-Jie Wang, et al.
Data in Brief|July 29, 2015
Data from a proteomic analysis of colonic fibroblasts secretomesSun-Xia Chen, Xiao-En Xu, Xiao-Qing Wang, et al.
Journal of Proteomics|August 14, 2014
Identification of colonic fibroblast secretomes reveals secretory factors regulating colon cancer cell proliferationSun-Xia Chen, Xiao-En Xu, Xiao-Qing Wang, et al.
Pageof 3